logo

Eli Lilly And Co. (LLY)



Trade LLY now with
  Date
  Headline
5/15/2018 6:46:11 AM Lilly's Galcanezumab Meets Primary Endpoint In Phase 3 Study Of Galcanezumab For Prevention Of Episodic Cluster Headache
5/14/2018 7:55:23 AM Lilly To Buy AurKa Pharma
5/14/2018 7:45:53 AM Eli Lilly To Acquire AurKa Pharma
5/10/2018 7:33:08 AM Elanco Animal Health Names Michael-Bryant Hicks As General Counsel
5/10/2018 7:31:27 AM Eli Lilly To Acquire ARMO BioSciences For $50/Shr Or $1.6 Bln, In All-cash Transaction
5/7/2018 3:33:20 PM Eli Lilly And Co. (LLY) Declares Quarterly Dividend of $ 0.5625, Record Date 5/17/2018
5/1/2018 9:55:34 AM Lilly And Local Partners Unveil Diabetes Prevention And Management Pilot In 3 Underserved Neighborhoods In Indianapolis
4/30/2018 6:46:50 AM Leena Gandhi To Lead Lilly Oncology Immuno-Oncology Medical Development
4/25/2018 6:47:29 AM Lilly And China's NCCD Announce Collaboration To Advance Care For People Living With Diabetes And Cardiovascular Disease
4/24/2018 6:31:24 AM Eli Lilly And Co. (LLY) Has Raised Its 2018 EPS Estimate To 5.10 - 5.20 From 4.81 - 4.91
4/24/2018 6:30:53 AM Eli Lilly And Co. (LLY) Has Raised Its 2018 Revenue Estimate To $23.7 Bln - $24.2 Bln From $23.0 Bln - $23.5 Bln
4/24/2018 6:25:57 AM Lilly Q1 Reported EPS $1.16 Vs Loss $0.10 Last Year
4/24/2018 6:02:26 AM Eli Lilly Reports Results From A Post-hoc Subgroup Analysis Which Demonstrated Efficacy Of Galcanezumab